Predictions
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.62
14.07.20
14.07.20
-
15.07.20
15.07.20
-12.15%
15.07.20
15.07.20
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Ipsen S.A.
Start price
Target price
Perf. (%)
€81.00
13.07.20
13.07.20
€95.00
04.11.21
04.11.21
12.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.65
12.07.20
12.07.20
-
17.10.20
17.10.20
9.93%
17.10.20
17.10.20
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Purple Biotech Ltd. ADR
Start price
Target price
Perf. (%)
€7.10
11.07.20
11.07.20
€6.00
04.11.21
04.11.21
-43.38%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Pfizer Inc.
Start price
Target price
Perf. (%)
€28.84
01.07.20
01.07.20
€42.69
08.07.20
08.07.20
-2.30%
08.07.20
08.07.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Inovio Pharma
Start price
Target price
Perf. (%)
€25.80
30.06.20
30.06.20
-
04.11.21
04.11.21
-72.73%
17.06.21
17.06.21
Probably not worthwhile Investment
Chugai Pharmaceutical Co Ltd
Start price
Target price
Perf. (%)
€49.67
26.06.20
26.06.20
-
31.07.20
31.07.20
-21.88%
31.07.20
31.07.20
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.48
19.06.20
19.06.20
€55.00
04.11.21
04.11.21
12.05%
04.04.21
04.04.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€22.00
16.06.20
16.06.20
-
02.07.20
02.07.20
35.45%
02.07.20
02.07.20
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Eurobio scientific
Start price
Target price
Perf. (%)
€7.42
06.06.20
06.06.20
€20.00
04.11.21
04.11.21
131.94%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Evofem Biosciences Inc.
Start price
Target price
Perf. (%)
€46.05
06.06.20
06.06.20
€45.00
04.11.21
04.11.21
-81.42%
05.11.21
05.11.21
Risky Investment
Lysogene SA
Start price
Target price
Perf. (%)
€2.80
05.06.20
05.06.20
€3.30
04.11.21
04.11.21
-18.39%
24.09.21
24.09.21
Could be worthwhile Investment >10% per year
Hexo Corp.
Start price
Target price
Perf. (%)
€35.28
02.06.20
02.06.20
€42.00
17.06.20
17.06.20
19.05%
17.06.20
17.06.20
Higher risks for its business
Novacyt S.A.
Start price
Target price
Perf. (%)
€3.70
31.05.20
31.05.20
€5.00
04.11.21
04.11.21
-12.32%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€8.08
29.05.20
29.05.20
€11.00
04.11.21
04.11.21
9.22%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.20
28.05.20
28.05.20
-
09.07.20
09.07.20
-35.59%
09.07.20
09.07.20
Evofem Biosciences Inc.
Start price
Target price
Perf. (%)
€102.90
25.05.20
25.05.20
€135.00
04.11.21
04.11.21
-86.11%
17.06.21
17.06.21
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected